Table 2 Final pathological results
TBNA Pathology (n = 245) | Number (%) |
|---|---|
Malignant | 147 |
 Adenocarcinoma | 73 (49.66) |
 Small cell carcinoma* | 26 (17.69) |
 Squamous cell carcinoma | 23 (15.66) |
 Undifferentiated/poorly differentiated carcinoma | 18 (12.24) |
 Metastasis of breast cancer | 2 (1.38) |
 Sarcoma | 1 (0.69) |
 Diffuse large B-cell lymphoma | 1 (0.69) |
 Multiple myeloma | 1 (0.69) |
 Thymoma, type B3 | 1 (0.69) |
 Adenoid cystic carcinoma | 1 (0.69) |
Benign | 99 |
 Sarcoidosis | 36 (36.36) |
 No abnormality identified | 35 (35.35) |
 Inflammation | 16 (16.16) |
 Tuberculosis* | 8 (8.08) |
 Pneumoconiosis | 3 (3.03) |
 Actinomycetes | 1 (1.01) |